Presentation at the conference “Response and Resistance in Cancer therapy” on September 9, 2018 in Kent, UK

CEO Nils Brünner will present data on SCO-101 and chemotherapy resistance at a conference in Kent, UK. The conference is organized by The British Association for Cancer Research and leading experts in the field of resistance to cancer therapy will be present.